Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenergic blocker therapy and the trabecular meshwork.

J Gottanka1, D H Johnson, P Martus

  • 1Department of Anatomy II, University of Erlangen-Nürnberg, Universitätsstrasse 19, 91054 Erlangen, Germany.

Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie
|May 25, 2001
PubMed
Summary

Beta-blocker therapy for glaucoma did not cause trabecular meshwork changes related to underperfusion. Aqueous humor flow likely utilizes preferential pathways within the trabecular meshwork.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis.

Alimentary pharmacology & therapeutics·2014
Same author

Baseline tumour measurements predict survival in advanced non-small cell lung cancer.

British journal of cancer·2013
Same author

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Dual-scan acquisition for accelerated continuous-wave EPR oximetry.

Journal of magnetic resonance (San Diego, Calif. : 1997)·2012
Same author

Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab.

Lung cancer (Amsterdam, Netherlands)·2012

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Cell Biology

Background:

  • Glaucoma is a leading cause of irreversible blindness.
  • Trabecular meshwork (TM) dysfunction is a key factor in primary open-angle glaucoma (POAG).
  • Beta-adrenergic blockers (beta-blockers) are commonly used to manage intraocular pressure in glaucoma patients.

Purpose of the Study:

  • To investigate whether beta-blocker therapy for glaucoma induces changes in the trabecular meshwork.
  • To assess potential underperfusion-related alterations in the TM structure due to beta-blocker use.

Main Methods:

  • Utilized transmission electron microscopy to examine the TM in human POAG donor eyes.
  • Compared TM extracellular material, lamellar structure, and cell pigmentation across three groups: beta-blocker treated, non-beta-blocker treated, and untreated elevated intraocular pressure.

Related Experiment Videos

  • Included normal donor eyes as controls.

    • Main Results:

    • No discernible TM changes were observed in eyes treated with beta-blockers.
    • Extracellular matrix composition and lamellar morphology were consistent across POAG groups.
    • Trabecular cell pigmentation correlated with aqueous flow, appearing more in regions with normal lamellae.

    Conclusions:

    • Beta-blocker therapy did not demonstrate evidence of causing underperfusion-induced TM changes.
    • Findings suggest the existence of preferential aqueous humor outflow pathways within the TM.
    • Trabecular cell pigmentation serves as a potential indicator of aqueous flow dynamics.